"Boston Children's in Boston, MA has always embodied a culture of innovation and scientific discovery, with the goal of improving the lives of children and families. This legacy continues today as we lead the world in pediatric research, empowering our clinicians and scientists to challenge the status quo and seek better answers for children everywhere."

During the past decade, HMS - Children's Hosp. Boston, Div. of Infectious Diseases conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "HMS - Children's Hosp. Boston, Div. of Infectious Diseases" #1 collaborator was "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)" with 20 trials as a collaborator, "Bristol-Myers Squibb" with 3 trials as a collaborator, "Glaxo Wellcome" with 3 trials as a collaborator, "Genentech, Inc." with 2 trials as a collaborator and "Hoffmann-La Roche" with 2 trials as a collaborator. Other collaborators include 1 different institutions and companies that were collaborators in the rest 11 trials.

According to Clinical.Site data, the most researched conditions in "HMS - Children's Hosp. Boston, Div. of Infectious Diseases" are "HIV Infections" (34 trials), "Pregnancy" (3 trials), "HIV Seronegativity" (2 trials), "Influenza" (2 trials) and "Measles" (2 trials). Many other conditions were trialed in "HMS - Children's Hosp. Boston, Div. of Infectious Diseases" in a lesser frequency.

Most popular intervention types in "HMS - Children's Hosp. Boston, Div. of Infectious Diseases" are "Drug" (22 trials), "Biological" (12 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Zidovudine" (9 trials), "Lamivudine" (4 trials), "Zalcitabine" (4 trials), "Didanosine" (3 trials) and "Nelfinavir mesylate" (3 trials). Other intervention names were less common.

The vast majority of trials in "HMS - Children's Hosp. Boston, Div. of Infectious Diseases" are 33 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "HMS - Children's Hosp. Boston, Div. of Infectious Diseases". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 36 completed trials in HMS - Children's Hosp. Boston, Div. of Infectious Diseases, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in HMS - Children's Hosp. Boston, Div. of Infectious Diseases, 18 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 5 trials that are defined as “Not Applicable".